Simulations Plus Income After Taxes 2010-2024 | SLP
Simulations Plus income after taxes from 2010 to 2024. Income after taxes can be defined as earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.
Simulations Plus Annual Income After Taxes
(Millions of US $) |
| 2024 |
$10 |
| 2023 |
$10 |
| 2022 |
$12 |
| 2021 |
$10 |
| 2020 |
$9 |
| 2019 |
$9 |
| 2018 |
$9 |
| 2017 |
$6 |
| 2016 |
$5 |
| 2015 |
$4 |
| 2014 |
$3 |
| 2013 |
$3 |
| 2012 |
$3 |
| 2011 |
$3 |
| 2010 |
$2 |
| 2009 |
$1 |
Simulations Plus Quarterly Income After Taxes
(Millions of US $) |
| 2024-08-31 |
$1 |
| 2024-05-31 |
$3 |
| 2024-02-29 |
$4 |
| 2023-11-30 |
$2 |
| 2023-08-31 |
$1 |
| 2023-05-31 |
$4 |
| 2023-02-28 |
$4 |
| 2022-11-30 |
$1 |
| 2022-08-31 |
$1 |
| 2022-05-31 |
$4 |
| 2022-02-28 |
$4 |
| 2021-11-30 |
$3 |
| 2021-08-31 |
$0 |
| 2021-05-31 |
$4 |
| 2021-02-28 |
$3 |
| 2020-11-30 |
$2 |
| 2020-08-31 |
$2 |
| 2020-05-31 |
$3 |
| 2020-02-29 |
$2 |
| 2019-11-30 |
$2 |
| 2019-08-31 |
$2 |
| 2019-05-31 |
$3 |
| 2019-02-28 |
$2 |
| 2018-11-30 |
$2 |
| 2018-08-31 |
$1 |
| 2018-05-31 |
$2 |
| 2018-02-28 |
$3 |
| 2017-11-30 |
$2 |
| 2017-08-31 |
$1 |
| 2017-05-31 |
$2 |
| 2017-02-28 |
$1 |
| 2016-11-30 |
$1 |
| 2016-08-31 |
$1 |
| 2016-05-31 |
$2 |
| 2016-02-29 |
$1 |
| 2015-11-30 |
$1 |
| 2015-08-31 |
$0 |
| 2015-05-31 |
$2 |
| 2015-02-28 |
$1 |
| 2014-11-30 |
$1 |
| 2014-08-31 |
$0 |
| 2014-05-31 |
$1 |
| 2014-02-28 |
$1 |
| 2013-11-30 |
$1 |
| 2013-08-31 |
$0 |
| 2013-05-31 |
$1 |
| 2013-02-28 |
$1 |
| 2012-11-30 |
$1 |
| 2012-08-31 |
$0 |
| 2012-05-31 |
$1 |
| 2012-02-29 |
$1 |
| 2011-11-30 |
$1 |
| 2011-08-31 |
$0 |
| 2011-05-31 |
$1 |
| 2011-02-28 |
$1 |
| 2010-11-30 |
$1 |
| 2010-08-31 |
$0 |
| 2010-05-31 |
$1 |
| 2010-02-28 |
$1 |
| 2009-11-30 |
$0 |
| 2009-08-31 |
$0 |
| 2009-05-31 |
$1 |
| 2009-02-28 |
$0 |
| Sector |
Industry |
Market Cap |
Revenue |
| Computer and Technology |
Computer Software |
$0.554B |
$0.070B |
|
Simulations Plus, Inc., is a premier developer of groundbreaking drug discovery and development simulation software, which is licensed to and used in the conduct of drug research by major pharmaceutical and biotechnology companies worldwide. They have two other businesses, Words+, Inc. and FutureLab, which are based on its proprietary software technologies.
|
